OTC Medications Could Make a Difference for Symptomatic Relief of Inhaled Irritants
OTC products for symptom relief1
Many common respiratory symptoms are associated with excess mucus, congestion, and cough. Symptom relief is important for patients' health.1
When a viral condition is present, some symptoms may be treated without the use of antibiotics.1
OTC medications may provide effective relief of excess mucus, cough, and congestion2
| Treatment: | Used to: |
|---|---|
| Expectorants (eg, guaifenesin) |
Thin bronchial secretions
By thinning and loosening mucus, expectorants improve mucociliary clearance, resulting in more productive coughs3 Expectorants commonly found in OTC cough suppressants are available in4:
Expectorants can also be used in combination with oral, single-ingredient decongestants, and/or antitussives.1,2,4 |
| Decongestants (eg, pseudoephedrine) |
Relieve nasal congestion and sinus pressure
By producing nasal vasoconstriction of the mucosal capillaries, decongestants shrink swollen nasal mucous membranes, reducing nasal congestion and increasing the drainage of sinus secretions5 Important considerations:
|
| Antitussives (eg, dextromethorphan) |
Suppress cough
Coughing is linked with a broad range of disease states and can represent an annoyance to patients. Antitussives work directly on the "cough center" of the brain to elevate the threshold for coughing and help reduce the frequency and/or intensity of coughing.6 Two of the most widely used antitussives are7:
|
*This is only a selected list and not all inclusive
References: 1. Mossad SB. Upper respiratory tract infections. Cleveland Clinic Web site. Revised July 29, 2005. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectiousdisease/urti/urti.htm Accessed June 17, 2008. 2. OTC Cough/Cold Drug Products. 21 CFR Part 341. 3. US Food and Drug Administration Web site. Labeling of expectorant drug products. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm. Accessed January 6, 2009. 4. MedlinePlus Web site. Guaifenesin. http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682494.html. Accessed July 15, 2008. 5. Puruckherr M, Byrd R, Roy T, Krishnaswamy G. The diagnosis and management of chronic rhinosinusitis. http://66.102.1.104/scholar?hl=en&lr=&q=cache:ITpy5H_AK1EJ:www.priory.com/med/rhinitis.htm. Accessed January 6, 2009. 6. US Food and Drug Administration Web site. Labeling of antitussive drug products. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm. Accessed February 26, 2008. 7. Bolser DC. Current and future centrally acting antitussives. Respir Physiol Neurobiol. 2006;152:349-355.







